The assessment of molecules comprising the blood–testis barrier (BTB) revealed decreased gene expression levels of occludin (Ocln) and claudin-3 (Cldn3) in the testes of CTR-Apt-treated DM mice (Figure 2F). Here, CLDN3 is linked to diabetes mellitus.